NILAM PATEL: Open Payments
NPI 1548538739 · RIDLEY PARK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,423 in 201 payments from 30 companies in 2025. Trend: 2023 $2,501 · 2024 $3,021 · 2025 $3,423
Food & beverage: $3,423
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $576 |
| Novo Nordisk Inc | 21 | $331 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 24 | $330 |
| GlaxoSmithKline, LLC. | 13 | $257 |
| PFIZER INC. | 17 | $225 |
| Kowa Pharmaceuticals America, Inc. | 19 | $208 |
| Lilly USA, LLC | 9 | $193 |
| Exact Sciences Corporation | 9 | $184 |
| AstraZeneca Pharmaceuticals LP | 8 | $181 |
| Astellas Pharma US Inc | 6 | $130 |
Products named: VRAYLAR, XIFAXAN, ZORYVE, Cologuard Collection Kit, TRELEGY ELLIPTA, REXULTI, UBRELVY, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
